SBIO vs. GERM
SBIO (ALPS Medical Breakthroughs ETF) and GERM (Amplify Treatments, Testing and Advancements ETF) are both Health & Biotech Equities funds - SBIO tracks the S-Network Medical Breakthroughs Index while GERM tracks the Prime Treatments, Testing and Advancements Index. Both are passively managed. Over the past year, SBIO returned 97.46% vs 0.00% for GERM. SBIO charges 0.50%/yr vs 0.68%/yr for GERM.
Performance
SBIO vs. GERM - Performance Comparison
Loading charts...
Returns By Period
SBIO
- 1D
- 0.82%
- 1M
- 10.96%
- YTD
- 15.46%
- 6M
- 14.04%
- 1Y
- 97.46%
- 3Y*
- 24.04%
- 5Y*
- 4.26%
- 10Y*
- 11.23%
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
SBIO vs. GERM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
SBIO ALPS Medical Breakthroughs ETF | 15.46% | 55.07% | -6.08% |
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% |
SBIO vs. GERM - Sectors Allocation Comparison
Sectors
SBIO
GERM
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Financial Services
Healthcare
SBIO
GERM
Basic Materials
SBIO
-
GERM
-
Communication Services
SBIO
-
GERM
-
Consumer Cyclical
SBIO
-
GERM
-
Consumer Defensive
SBIO
-
GERM
-
Energy
SBIO
-
GERM
-
Industrials
SBIO
-
GERM
-
Real Estate
SBIO
-
GERM
-
Technology
SBIO
-
GERM
-
Utilities
SBIO
-
GERM
-
Financial Services
SBIO
GERM
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SBIO vs. GERM — Risk / Return Rank
SBIO
GERM
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
SBIO vs. GERM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SBIO | GERM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.48 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 7.74 | — | — |
| Martin ratioReturn relative to average drawdown | 21.59 | — | — |
Loading charts...
Drawdowns
SBIO vs. GERM - Drawdown Comparison
The maximum SBIO drawdown since its inception was -63.06%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for SBIO and GERM.
Loading charts...
Drawdown Indicators
| SBIO | GERM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.06% | 0.00% | -63.06% |
Max Drawdown (1Y)Largest decline over 1 year | -12.66% | 0.00% | -12.66% |
Max Drawdown (3Y)Largest decline over 3 years | -42.44% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -53.10% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -63.06% | — | — |
Current DrawdownCurrent decline from peak | -3.55% | 0.00% | -3.55% |
Average DrawdownAverage peak-to-trough decline | -28.37% | 0.00% | -28.37% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.53% | 0.00% | +4.53% |
Volatility
SBIO vs. GERM - Volatility Comparison
ALPS Medical Breakthroughs ETF (SBIO) has a higher volatility of 11.06% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that SBIO's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SBIO | GERM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.06% | 0.00% | +11.06% |
Volatility (6M)Calculated over the trailing 6-month period | 23.78% | 0.00% | +23.78% |
Volatility (1Y)Calculated over the trailing 1-year period | 30.40% | 0.00% | +30.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.75% | 0.00% | +33.75% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.19% | 0.00% | +33.19% |
SBIO vs. GERM - Expense Ratio Comparison
SBIO has a 0.50% expense ratio, which is lower than GERM's 0.68% expense ratio.
Dividends
SBIO vs. GERM - Dividend Comparison
Neither SBIO nor GERM has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% |
Frequently Asked Questions
SBIO has higher volatility (11.06%) compared to GERM (0.00%). In terms of maximum drawdown, SBIO dropped -63.06% vs GERM's 0.00%.
On 1-year performance, SBIO leads with 97.46% vs 0.00% for GERM. On fees, SBIO is cheaper at 0.50% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, SBIO has performed better with a 97.46% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SBIO is cheaper with a 0.50% expense ratio, compared with 0.68% for GERM.
SBIO and GERM have nearly identical dividend yields, around 0.00%.
SBIO tracks S-Network Medical Breakthroughs Index, while GERM tracks Prime Treatments, Testing and Advancements Index. They also come from different issuers: SS&C and Amplify. Their fees differ too: 0.50% for SBIO and 0.68% for GERM.
Find the right allocation for SBIO and GERM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer